The course of inhalation profiles during an exacerbation of obstructive lung disease.

BACKGROUND Acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD) are associated with increased airflow Limitation, hyperinflation and respiratory muscle fatigue. It is unclear, whether patients are able to perform adequate inhalations through various inhalation devices with different orfices during an exacerbation. The aim of this study was to examine the evolution of inhalation profiles of patients inhaling through Diskus, Turbuhaler, pressurized metered dose inhaler (pMDI) and Volumatic and consequently the appropriateness of using the various devices during an exacerbation. MEASUREMENTS 15 hospitalized patients participated in this randomized comparison of inhalation profiles through the four placebo-devices. For each device, triplicate inhalation profiles were recorded during day 1-9 of admission and in stable phase (day 50). RESULTS The mean percentage of patients performing optimum inhalation profiles was 100% for Diskus, 60% for Turbuhaler, 14% for pMDI and 87% for Volumatic over the interval of day 1-9 and day 50. Patients with an inspiratory muscle strength (MIP) of less than 6kPa were generally unable to generate the optimum flow through the Turbuhaler (>60 l/min). CONCLUSION The Diskus and Volumatic can be used effectively in the acute phase of an exacerbation of asthma or COPD. The Turbuhaler could be optimally used after the fifth day of convalescence. The pMDI is rather unsuitable during an exacerbation.

[1]  H. Bisgaard,et al.  Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children. , 1998, The European respiratory journal.

[2]  A. Idris,et al.  Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. , 1993, Chest.

[3]  S. H. Wilson,et al.  Predicted normal values for maximal respiratory pressures in caucasian adults and children. , 1984, Thorax.

[4]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[5]  K. Nikander,et al.  Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). , 1990, The European respiratory journal.

[6]  J. Bousquet,et al.  International consensus report on diagnosis and management of asthma , 1992, Allergy.

[7]  M. Bala,et al.  Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. , 2000, Chest.

[8]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[9]  C. O’Callaghan,et al.  Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation? , 1994, Thorax.

[10]  B. Lask.  International Consensus Report on Diagnosis and Management of Asthma , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  A. Cartier,et al.  Patient handling of a multidose dry powder inhalation device for albuterol. , 1994, Chest.

[12]  G. Crompton,et al.  Peak inspiratory flow through Turbuhaler in acute asthma. , 1995, The European respiratory journal.

[13]  L. S. Hill,et al.  A comparison of the performance of two modern multidose dry powder asthma inhalers. , 1998, Respiratory medicine.

[14]  J. M. FitzGerald,et al.  Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.

[15]  H. Bisgaard,et al.  Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma. , 1998, The European respiratory journal.

[16]  E. Israel,et al.  The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. , 1994, American journal of respiratory and critical care medicine.

[17]  I. Mesters,et al.  Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

[18]  N. Molfino,et al.  Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. , 1997, Chest.

[19]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[20]  B. Ekholm,et al.  Evaluation of conventional press-and-breathe metered-dose inhaler technique in 501 patients. , 1994, The Journal of asthma : official journal of the Association for the Care of Asthma.

[21]  S. Clarke,et al.  Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy , 1991 .

[22]  N Roche,et al.  Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability , 2002, European Respiratory Journal.

[23]  N. Eiser,et al.  Does the mode of inhalation affect the bronchodilator response in patients with severe COPD? , 2001, Respiratory medicine.

[24]  J. J. Klein,et al.  Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines. , 1997, Patient education and counseling.

[25]  G. Crompton,et al.  Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease. , 1999, Respiratory medicine.

[26]  P. Barry,et al.  Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. , 1994, The European respiratory journal.

[27]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[28]  R. Pauwels,et al.  Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers. , 1997, The European respiratory journal.

[29]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.